APA

Mandorfer M., Neukam K., Rivero A., Puoti M., Boesecke C., Baumgarten A., Grzeszczuk A., Zangerle R., Ernst D., Rockstroh J. K., Trauner M., Pineda J. A., Peck-Radosavljevic M. & Reiberger T. (20150522). Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy. : Antiviral therapy.

Chicago

Mandorfer Mattias, Neukam Karin, Rivero Antonio, Puoti Massimo, Boesecke Christoph, Baumgarten Axel, Grzeszczuk Anna, Zangerle Robert, Ernst Diana, Rockstroh Jürgen Kurt, Trauner Michael, Pineda Juan Antonio, Peck-Radosavljevic Markus and Reiberger Thomas. 20150522. Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy. : Antiviral therapy.

Harvard

Mandorfer M., Neukam K., Rivero A., Puoti M., Boesecke C., Baumgarten A., Grzeszczuk A., Zangerle R., Ernst D., Rockstroh J. K., Trauner M., Pineda J. A., Peck-Radosavljevic M. and Reiberger T. (20150522). Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy. : Antiviral therapy.

MLA

Mandorfer Mattias, Neukam Karin, Rivero Antonio, Puoti Massimo, Boesecke Christoph, Baumgarten Axel, Grzeszczuk Anna, Zangerle Robert, Ernst Diana, Rockstroh Jürgen Kurt, Trauner Michael, Pineda Juan Antonio, Peck-Radosavljevic Markus and Reiberger Thomas. Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy. : Antiviral therapy. 20150522.